Relay Therapeutics, Inc. RLAY Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s other operating expenses?
- Relay Therapeutics, Inc. (RLAY) reported other operating expenses of $81.59M in Q1 2026.
- How has Relay Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Relay Therapeutics, Inc.'s other operating expenses decreased by 11.8% year-over-year, from $92.55M to $81.59M.
- What is the long-term trend for Relay Therapeutics, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s other operating expenses has grown at a -3.6% compound annual growth rate (CAGR), from $367.73M to $318.09M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.